AASANDHA SCHEME
Master Medicine and Consumable list as at 14th May 2026
test
| Code | mfda_code | Generic | Product name | Strength | Volume | Preparation | Master Price (MVR) |
|---|---|---|---|---|---|---|---|
| M3740 | P4278 | Cefixime | Trifix 200 | 200 mg | Tablet | 6 | |
| M3585 | P4954 | Cefixime + Clavulanic Acid | Omnicef-O CV 200 | 200 mg + 125 mg | Tablet | 9.86 | |
| TM0590 | P3850 | Cefixime + Clavulanic Acid | Cefixime + Clavulanic Acid | 200 mg + 125 mg | Tablet | 12.24 | |
| M0542 | P2033 | Cefixime + Lactobacillus | Cefo L - 50 | 50 mg + 60 million spores | Tablet (DT) | 5.1 | |
| M0543 | P2034 | Cefixime + Lactobacillus | Cefo L - 100 | 100 mg + 60 million spores | Tablet (DT) | 4.08 | |
| M0544 | P2035 | Cefixime + Lactobacillus | Cefo L - 200 | 200 mg + 60 million spores | Tablet (DT) | 5.36 | |
| M0545 | P2036 | Cefixime + Lactobacillus | Cefo L | 50 mg per 5 ml | Oral Liquid | 24.62 | |
| M3365 | P3762 | Cefixime Trihydrate | Cef - 3 | 200 mg | Capsule | 8.16 | |
| M3837 | P5885 | Cefixime Trihydrate | Evofix suspension | 100 mg per 5ml | 60 ml | Oral Solution (Powder) | 71.09 |
| M3730 | P4277 | Cefixime USP | Trifix | 100 mg / 5ml | 30 ml | Dry Syrup | 57.55 |
| M0546 | P0875 | Cefotaxime | Cefotaxime | 1000 mg | Injection | 20.4 | |
| M0548 | P1071 | Cefotaxime | Cefantral | 1000 mg | Injection | 21.32 | |
| M0549 | P1072 | Cefotaxime | Cefantral | 500 mg | Injection | 10.2 | |
| M0551 | P4879 | Cefotaxime | Cefotaxime | 250 mg | Injection | 10.2 | |
| M0553 | P1733 | Cefotaxime | Zetaxim | 500 mg | Injection | 18.36 | |
| M0554 | P2813 | Cefotaxime | Zetaxim | 1000 mg | Injection | 16.32 | |
| M0555 | P2895 | Cefotaxime | Zetaxim | 500 mg | Injection | 12.24 | |
| M0556 | P2896 | Cefotaxime | Zetaxim | 1000 mg | Injection | 30.6 | |
| M2817 | P1086 | Cefotaxime | Cefataxime | 1000 mg | Injection | 35.7 | |
| M3741 | P4477 | Cefotaxime | Kalfoxim | 1000 mg | Injection | 98.72 |